Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

MARKSANS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.0%1-day move

₹165.25

prior close

₹164.05

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.7-0.2-0.4+0.1-5.0+0.6+1.6+0.8+2.6+5.8+8.3+15.2+50.4+59.8

Up moveDown movePending

AI summary

Marksans Pharma has informed the stock exchanges that its trading window for designated persons and their immediate relatives will be closed from Wednesday, April 1, 2026, until 48 hours after the declaration of its Audited Financial Results for the quarter and financial year ending March 31, 2026. During this period, company insiders are prohibited from trading in the company's shares. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, typically undertaken ahead of quarterly results announcements.

Likely market impact

This is a standard regulatory disclosure and does not affect retail investors. It signals that the company's Q4 and FY26 audited results will be announced soon after May/June 2026, which may be a catalyst for stock movement depending on the numbers reported.